Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The subscription period for Inhalation Sciences' rights issue begins today

Today on April 24, 2023, the subscription period begins in Inhalation Sciences Sweden AB (publ)’s ("ISAB" or the "Company") rights issue of shares (the “Rights Issue”). The Rights Issue was resolved by the Board of Directors on April 6, 2023, with support of the authorization from the Annual General Meeting on May 6, 2022. The subscription period runs until and including May 9, 2023.THIS DOCUMENT IS NOT TO BE DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release       24 April 2023 at 09.45 a.m. (EEST) Sitowise Group Plc (the "Company") has on 21 April 2023 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley & Co. International plc, according to which Morgan Stanley & Co. International plc's holding of the shares and votes of the Company has fallen below the threshold of 5 percent on 20 April 2023. According to the notification, Morgan Stanley & Co. International plc holds a total of 202,307 shares through financial instruments

poLight ASA: Last day of trading in Subscription Rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to previous stock exchange announcements from poLight ASA ("poLight" or the "Company") regarding a fully underwritten rights issue of 12,918,660 new shares in the Company (the "Offer Shares"), raising gross proceeds of NOK 135 million (the "Rights Issue"). The

The Board of Directors in Brain+ A/S has resolved on the previously announced intention to execute a rights issue of units

COMPANY ANNOUNCEMENT Copenhagen, Denmark, April 24, 2023 – Brain+ A/S (Nasdaq First North: BRAINP)NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. The Board of Directors in Brain+ A/S (“Brain+” or the “Company”) has, with the mandated authorization from the extraordinary

Extended warranty for Rototilt machine couplers

Rototilt is introducing a two-year warranty on all new machine couplers delivered from 1 January 2023. As a result, the standard warranty is being extended from one to two years. “We set ourselves apart by calculating the warranty period from the delivery date, rather than limiting it to a maximum number of hours of use. Our machine couplers are robust and stable, which enables us to offer a two-year warranty,” says Jan Karlsson, Head of Orders and Aftermarket at Rototilt.The warranty is valid immediately on delivery, without any registration requirement. Rototilt also always offers a

Insider Acquisitions in Phase Holographic Imaging

CEO Patrik Eschricht, chairman Peter Egelberg and deputy board member Ann Christine Egelberg has recently acquired additional holdings in Phase Holographic Imaging.Respectively on April 19 and April 21, 2023, Patrik Eschricht acquired shares totaling 206 472 SEK and acquired 1 250 TO 3 warrants that will be subscribed for a value of 4 725 SEK. After recently acquiring additional TO 3 warrants on April 21, 2023, Peter and Ann Christine Egelberg subscribed to all TO 3 warrants held privately and by fully owned companies for a total of 121 856 SEK on April 24, 2023.

Norwegian healthcare region expands solution from Sectra with digital pathology to improve cancer care

Linköping, Sweden – April 24, 2023 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has expanded its current contract with the South-Eastern Norway Regional Health Authority—Helse Sør-Øst RHF (HSØ). HSØ will add Sectra’s digital pathology module to the Sectra Enterprise Imaging Solution. This will enable pathology labs in the region to share resources, expertise, and workloads, thus ensuring high-quality cancer care for patients.“Going digital in pathology is an important step to ensure that we can continue to provide high-quality care

Valmet to deliver paper machine clothing for the start-up of Batı Kipaş Kağıt’s new PM 3 in Turkey

Valmet Oyj’s trade press release April 24, 2023 at 9:30 a.m. EESTValmet will deliver a comprehensive paper machine clothing package to the new board making line (PM 3) of Batı Kipas Kagıt Sanayi İsletmeleri  in Söke, Turkey. The customer selected Valmet’s paper machine clothing to ensure a successful start-up of their new Valmet board making line later this year. The package corresponds to a clothing consumption of several years. The order is included in Valmet's

HC Andersen Capital Events 24/04: Meet the top management in Hansa Biopharma & Inderes

HC Andersen Capital is hosting digital events where you can meet and ask questions directly to the top management. It is free for all to attend.Hansa Biopharma - Presentation of Q1 interim report 2023Hansa Biopharma published its Q1 report on April 20th. On that occasion, HC Andersen Capital will be hosting a digital event on Monday, April 24th at 13.00 where you will be able to meet Head Of Investor Relations Klaus Sindahl who will review highlights from the report and the quarter in general, and take questions.   Disclaimer: HC Andersen Capital receives payment from Hansa

Kyoto Group: Annual report 2022 and business update

Oslo, Norway 24 April 2023 – Kyoto Group today published its 2022 Annual Report and will provide a live business update on the commercialization of its Heatcube thermal energy storage solution.“2022 was a year of tremendous progress for Kyoto. We installed the first commercial Heatcube, built a strong commercial pipeline, launched the second-generation Heatcube and significantly strengthened the organization. This formed the foundation for the recently announced cooperation with a world-leading renewable energy company, providing us with game-changing market access in 2023,” says Camilla

Wulff Group Plc’s Interim Report for January 1 – March 31, 2023

INTERIM REPORT | APRIL 24, 2023 AT 9.30 A.M. This is a summary of Wulff Group Plc’s Interim Report for January-March 2022. Wulff Group’s Interim Report as a whole is attached as a PDF file to this stock exchange release and it is also available on the company’s website www.wulff.fi/en. Wulff’s fine Q1: profitability remained good - turnover decreased slightly 1.1.-31.3.2023 BRIEFLY · Net sales totalled EUR 25.3 million (25.6), increased by 1.4 %. · EBITDA and comparable EBITDA were EUR 1.4 million (1.8). · Operating profit and comparable operating profit (EBIT) amounted

Development update: Autogun Heroes strong performance continued

Autogun Heroes has continued its strong performance ahead of the upcoming hard launch.“We have continued to see exceptional results with Autogun Heroes. The new data especially from iOS further supports our earlier conclusions and increases our excitement about the long-term potential with the game.” says Jussi Tähtinen, CEO of Nitro Games. Autogun Heroes has a strong long-term retention. The 30 days retention has been trending upwards, currently at 6% with a steady curve beyond that. The monetisation is the strongest part of the game with users converting to paying customers already

Q1/2023: Profitable growth – 13% EBITDA margin

LeadDesk Plc unofficial translation of Company Release 24/4/2023 at 9.15 amFigures in parentheses refer to the equivalent period in the previous year unless otherwise stated. Figures presented in this business review are unaudited.  January–March 2023 · Revenue EUR 7,259 (6,850) thousand, growth 6.0% · Annual recurring revenue contract base EUR 24,711 (23,036) thousand, growth 7.3% · EBITDA EUR 916 (685) thousand, 12.6% (10.0) of revenue CEO Olli Nokso-Koivisto’s comments on the first quarter of 2024: ”LeadDesk is a leader in European cloud-based contact center

Notice of Extraordinary General Meeting of Clinical Laserthermia Systems AB

The shareholders of Clinical Laserthermia Systems AB, 556705-8903, are hereby invited to an Extraordinary General Meeting on Thursday May 25, 2023, at 10:00 CET, Medicon Village, Lund.Right to participate and registrationShareholders who wish to participate in the Meeting must · be entered in the share register maintained by Euroclear Sweden AB on Tuesday May 16, 2023, and · register with the company no later than Friday May 19, 2023, in writing to Clinical Laserthermia Systems AB, Medicon Village, Scheelegatan 2, 223 63 Lund. Registration can also be made by phone to +46 702 90

atNorth Receives ISO14001 Certification

atNorth strengthens its commitment to improving its environmental management responsibilities.Stockholm, Sweden – April 24, 2023 –  atNorth , the leading Nordic colocation, high-performance computing, and artificial intelligence service provider, has announced that it has recently received an ISO14001 certification for Environmental Management for both its Iceland and Sweden sites. The accreditation demonstrates atNorth’s continued commitment to carbon reduction, not just through the development of state-of-the-art sustainable data centers, but also as a common

Bexmarilimab Efficacy and Safety in MATINS Trial

Faron Pharmaceuticals Oy   ("Faron or the Company")   Faron Announces Release of Research Confirming Bexmarilimab Efficacy and Safety in MATINS Trial   · Macrophage targeting can promote tumor stabilization in late-stage cancer · Bexmarilimab-induced macrophage activation with robust stimulation of IFN-γ and T-cell receptor signaling only in patients with disease control · Data confirms that bexmarilimab therapy is well-tolerated   Press Release, April 24, 2023   TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a

Clinical Laserthermia Systems intends to decide upon a rights issue of units of approximately SEK 135 million to support ongoing market introduction and strengthen the company's capital structure

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA, BELARUS OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES BEYOND THOSE REQUIRED BY SWEDISH LAW. PLEASE SEE "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE.   The board of directors of Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") announces its

Notice of AGM

24 April 2023 IOG plc  Notice of AGM IOG plc ("IOG", or "the Company"), (AIM: IOG.L) hereby gives notice of its 2023 Annual General Meeting (AGM). The Company's AGM will be held at 10.00am on 2 May 2023 at the offices of Fieldfisher, Riverbank House, 2 Swan Lane, London EC4R 3TT. The 2022 Annual Report and Accounts and the Notice of the Company's AGM was posted to shareholders on 6 April 2023. IOG is required to confirm all attendees ahead of the meeting. Shareholders wishing to join the AGM are therefore kindly requested to confirm their attendance by email to info@iog.co.uk

Handelsbanken’s Interim Report for January – March 2023 will be presented Wednesday 26 April

Handelsbanken publishes its interim report for January ­– March 2023, at 06:30 a.m. CET Wednesday, 26 April. The report, slide presentation and Fact Book will be published on handelsbanken.com/ir. The President and Group Chief Executive Officer Carina Åkerström will present the interim report at 08:30 a.m. CET. The presentation will be broadcast live in Swedish and available at handelsbanken.com/ir and with the option for simultaneous interpretation into English. The presentation will be followed by a short break, after which a Q&A session will be held in English for analysts,

Invitation to a press and analyst conference in Stockholm for presentation of Concentric’s Quarter One 2023 Interim Report

Concentric's Interim Report for Q1 January-March 2023, will be published on the 3 of May 2023, at 08.00 CET. At 10.00 CET media, investors and analysts are invited to Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm, for a presentation of the report. There will also be an opportunity to participate via webcast/telephone conference. President & CEO Martin Kunz and CFO Marcus Whitehouse will host the presentation, which will be held in English and is followed by a Q&A-session. We look forward to your participation. Please see the below detailed information to join in: Press

Nitro Games Oyj: Interim Report January – March 2023

Reporting period January – March 2023 · Revenues (Jan - Mar): 1 742,3 KEUR (1 133,3 KEUR). · EBITDA: -214,2 KEUR (-1 060,3 KEUR). · EBIT: - 462,1 KEUR (-1 262,8 KEUR). · Net result: -360,5 KEUR (-1 276,9 KEUR). · Earnings per share (EPS) 0,0 (-0,1). · Cash and cash equivalents: 1 683,4 KEUR, and 787,6 KEUR of short-term receivables (31 March 2023). (All figures are presented in accordance with IFRS and, unless otherwise stated, the comparison figures in brackets refer to the corresponding period in the previous year.) Significant events during January – March 2023

Kindred’s revenue from harmful gambling decreased to 3.0 per cent in the first quarter of 2023

In the first quarter of 2023, Kindred Group’s share of revenue from harmful gambling decreased to 3.0 per cent and the improvement effect after interventions was 83.0 per cent. During the quarter, effects of automated technological solutions such as detecting and engaging with customers at risk through automated interventions are showing initial signs of a positive trend.Kindred Group plc (Kindred) reports a decrease in the share of revenue from harmful gambling to 3.0 (3.3) per cent in the first quarter of 2023. This positive trend can be attributed to improvements focused on enhancing the

TOMRA: Invitation to Q1 2023 Presentation

TOMRA's first quarter 2023 results will be released Friday 28 April 2023. President & CEO Tove Andersen and CFO Eva Sagemo will present the results at 08:00 CEST. The presentation will be sent via live webcast. Questions to the speakers can be directed using the Q&A-tool embedded in the webcast and will be addressed towards the end of the presentation. A recorded version of the webcast will be available shortly after the webcast has concluded. Link to the webcast:  https://channel.royalcast.com/landingpage/hegnarmedia/20230428_9/ All written materials including interim report,

Year-end report January-March 2023

A strong start to the year Quarter 1, 2023 · Incoming orders amounted to SEK 1,505m (1,345), equivalent to currency neutral growth of 5.9 percent compared with the same period last year. · Net sales amounted to SEK 1,482m (1,094), equivalent to currency neutral growth of 27.6 percent compared with the same period last year. · Adjusted EBITA was SEK 172.7m (115.7), giving an adjusted EBITAmargin of 11.7 percent (10.6). · Operating profit totalled SEK 127.1m (98.2), corresponding to an operating margin of 8.6 percent (9.0). Operating profit included a restructuring cost of

There are no items matching the current filter
There are no more items matching the current filter
Back to top